We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




A Mass Spectrometry Approach for Monitoring Progress of Multiple Myeloma

By LabMedica International staff writers
Posted on 05 Apr 2021
Print article
Image: Artist`s depiction of myeloma cells producing monoclonal proteins of varying types (Photo courtesy of Wikimedia Commons)
Image: Artist`s depiction of myeloma cells producing monoclonal proteins of varying types (Photo courtesy of Wikimedia Commons)
An easy to perform mass spectrometry (MS) approach enables monitoring the progress of multiple myeloma by tracing unique clonal immunoglobulin gene fingerprints in blood samples.

Due to improved treatment, more patients with multiple myeloma (MM) reach a state of minimal residual disease (MRD). Different strategies for MM MRD monitoring that are currently available include flow cytometry, allele-specific oligonucleotide–quantitative PCR, next-generation sequencing, and mass spectrometry (MS). The last three methods rely on the presence and the stability of a unique immunoglobulin fingerprint derived from the clonal plasma cell population.

A novel approach for generating immunoglobulin fingerprints in MRD patients was developed by investigators at Radboud University Medical Center (Nijmegen, the Netherlands) and colleagues at Erasmus Medical Center (Rotterdam, the Netherlands). They created an analysis pipeline based on MiXCR (a universal tool for fast and accurate analysis of T- and B- cell receptor repertoire sequencing data) and HIGH-VQUEST (V-QUERy and STandardization - part of the international ImMunoGeneTics (IMGT) information system.

IMGT/HighV-QUEST is the high-throughput version of IMGT/V-QUEST for the analysis of thousands of immunoglobulin (IG) and T cell receptor (TR) rearranged nucleotide sequences per run. IMGT/HighV-QUEST was developed to cope with the problematic analysis of antigen receptor data from Next-Generation Sequencing (NGS). The investigators used these analysis techniques to identify clonal molecular fingerprints and their clonotypic peptides based on transcriptomic datasets.

The investigators reported in the March 12, 2021, online edition of the journal Clinical Chemistry that the analysis pipeline was successfully validated in MM cell lines. In a cohort of 609 patients with MM, they demonstrated that the most abundant clone harbored a unique clonal molecular fingerprint and that multiple unique clonotypic peptides compatible with MS measurements could be identified for all patients. Furthermore, the clonal immunoglobulin gene fingerprints of both the light and heavy chain remained stable during MM disease progression.

Senior author, Dr. Joannes F. M. Jacobs, a medical immunologist at Radboud University Medical Center, said, "The disease is found almost everywhere in the bone marrow, but in some areas you there are more cancerous cells than in other areas. So if you take a biopsy where there are fewer cancer cells, the test result does not accurately reflect the real situation. The new method makes it much easier to follow the progression of multiple myeloma. With a single drop of blood, it is possible to very accurately show whether the number of cancerous cells in the bone marrow is increasing in a patient. In time, this blood test could potentially replace the current bone marrow puncture."

Related Links:
Radboud University Medical Center
Erasmus Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.